Endotoxemia and gut barrier dysfunction in alcoholic liver disease.
about
Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease in focal cerebral ischemic ratsFundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's diseaseMetabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies?Multipotent mesenchymal stromal cells: A promising strategy to manage alcoholic liver diseaseProbiotics and Alcoholic Liver Disease: Treatment and Potential MechanismsThe Role of Innate Immunity in Alcoholic Liver DiseaseResearch advances in the relationship between nonalcoholic fatty liver disease and atherosclerosisKupffer cells in the liverAlcoholic liver disease: pathogenesis, management, and novel targets for therapyRole of innate immunity in the development of hepatocellular carcinomaChronic alcohol exposure renders epithelial cells vulnerable to bacterial infectionAlcoholic liver disease: pathogenesis and new therapeutic targets.Toll-like receptors in pathophysiology of liver diseasesRole of farnesoid X receptor and bile acids in alcoholic liver diseaseFatty acid ethyl esters induce intestinal epithelial barrier dysfunction via a reactive oxygen species-dependent mechanism in a three-dimensional cell culture model.Toll-Interacting Protein in Resolving and Non-Resolving Inflammation.Role of interleukin-22 in liver diseases.Alcohol, inflammation, and gut-liver-brain interactions in tissue damage and disease development.Efficiency of double layered microencapsulated probiotic to modulate proinflammatory molecular markers for the management of alcoholic liver disease.Acetaldehyde disrupts tight junctions in Caco-2 cell monolayers by a protein phosphatase 2A-dependent mechanism.Fibrogenesis in alcoholic liver disease.CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitisMolecular mechanisms of liver fibrosis in HIV/HCV coinfectionContribution of gut bacteria to liver pathobiology.Toll-like receptors in the pathogenesis of alcoholic liver disease.Inactivation of hepatocyte nuclear factor-4{alpha} mediates alcohol-induced downregulation of intestinal tight junction proteins.Tributyrin supplementation protects mice from acute ethanol-induced gut injury.Alcoholism: a systemic proinflammatory condition.Generation of a mouse model of T-cell lymphoma based on chronic LPS challenge and TGF-β signaling disruptionChronic liver inflammation: clinical implications beyond alcoholic liver disease.A critical role for human caspase-4 in endotoxin sensitivity.Role of Glutamine in Protection of Intestinal Epithelial Tight Junctions.Toll-like receptor-mediated signaling cascade as a regulator of the inflammation network during alcoholic liver disease.Pathogenesis of alcoholic liver disease: role of oxidative metabolism.Molecular mechanism for adiponectin-dependent M2 macrophage polarization: link between the metabolic and innate immune activity of full-length adiponectin.Innate immune programing by endotoxin and its pathological consequencesMolecular mechanisms of alcoholic liver disease: innate immunity and cytokines.Dietary zinc deficiency exaggerates ethanol-induced liver injury in mice: involvement of intrahepatic and extrahepatic factorsRedox signaling and the innate immune system in alcoholic liver disease.Intestinal lesions are associated with altered intestinal microbiome and are more frequent in children and young adults with cystic fibrosis and cirrhosis.
P2860
Q26747585-83D3C1FC-78F4-4DFE-A4D0-0D4885AFFEDEQ26748713-2C2351CD-1D07-45A7-ABC5-A77443AD9F7BQ26769611-D7796697-3914-4D81-A5C5-7D3B0617BB3BQ26769618-CECD6472-1AD4-499D-8345-852E15B7BDCFQ26770137-12451F68-3F30-4285-9D4D-2C5DFED2CFC3Q26773226-96C9CBBA-41B0-4A6E-8B57-A1CD76301468Q26775340-986A5462-EFD6-42A3-AFB8-52B73B3389C0Q26822031-B835A21C-9AEA-4862-BEFF-28190B177AE4Q26861620-B1D25575-1AD3-43BE-9AA8-175089562568Q27024780-21ACADD6-24EC-4B84-9BE8-8F6DC4AEE417Q27318533-2D900C73-3C6D-4B8B-9027-0CD4F5CDC447Q27690220-5593384B-0F02-43D8-9FF7-8705A817D88FQ28070077-63F11573-420A-480A-BD19-C3A67F871824Q28086898-1A50EC38-BC92-425E-BCC1-22D1F5CE6FAAQ31113913-DF3D0E0E-2F7D-40ED-AE2A-80C398D71ADAQ33639016-A7BB09F5-9726-49DF-A907-5F2B366B5B55Q33729412-E788BDEF-CEE4-46DA-9595-1ED3CEA38485Q33742449-854DC8E5-48F5-48DD-8511-C896284DAB69Q33748252-73E679E9-A671-4D36-A29E-E487CD3FED40Q33816854-D33B9490-FEEA-4B16-82CF-FFFED7D4AC87Q33845463-0D49890F-8B56-4B08-A8B7-5654B819F68EQ33882408-2C85D622-EC63-4678-B88B-19CF2B4DC166Q33907429-9658EA45-EB3A-49E6-803F-A70458D6FF49Q34035372-7EB756F2-1BB7-40D6-976A-03B1E6CA835FQ34106192-47A9BB09-CC38-41A0-BDD6-CCE5020B23C5Q34178804-CB43327D-757A-42A2-8FA7-4CFE485410A3Q34290107-482531B1-8A23-4F60-AB00-2203AB34877BQ34405036-47647886-070B-4378-BC07-628026658244Q34405481-3B59367E-2174-4764-A722-1AA02B1898B0Q34408850-1C167282-125E-426B-B090-FAD1F1FDF5F2Q34422142-3E20950A-41E0-4399-BDE8-B8DABA5FF6EDQ34468725-146A6F4E-CB50-419E-8E8E-1FDE53003751Q34589665-0935FF30-FF37-4F2E-96C2-8ADD2C17C592Q34750539-F53C07F2-3F68-475C-94A7-3BA2C1250E8CQ34787288-82134093-67E4-4D0A-B745-D5F1350388BFQ34841012-B8306E02-679F-4C5A-8265-9805DA5F233EQ34872953-0AB96E8F-CFA8-46E8-A89D-71D4257DCAF6Q35025292-F2E0B0C1-BFAC-4F05-BB6C-2D0F7893C406Q35055857-A6225C5D-97CA-4626-99EB-069CA76256C5Q35058280-78F206E2-E875-46C0-885F-A838B1389D4D
P2860
Endotoxemia and gut barrier dysfunction in alcoholic liver disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Endotoxemia and gut barrier dysfunction in alcoholic liver disease.
@en
Endotoxemia and gut barrier dysfunction in alcoholic liver disease.
@nl
type
label
Endotoxemia and gut barrier dysfunction in alcoholic liver disease.
@en
Endotoxemia and gut barrier dysfunction in alcoholic liver disease.
@nl
prefLabel
Endotoxemia and gut barrier dysfunction in alcoholic liver disease.
@en
Endotoxemia and gut barrier dysfunction in alcoholic liver disease.
@nl
P356
P1433
P1476
Endotoxemia and gut barrier dysfunction in alcoholic liver disease.
@en
P2093
Radhakrishna Rao
P304
P356
10.1002/HEP.23009
P407
P577
2009-08-01T00:00:00Z